3-38307600-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001320033.2(SLC22A14):c.655C>G(p.Leu219Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. L219L) has been classified as Likely benign.
Frequency
Consequence
NM_001320033.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A14 | NM_001320033.2 | c.655C>G | p.Leu219Val | missense_variant | 4/11 | ENST00000448498.6 | NP_001306962.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A14 | ENST00000448498.6 | c.655C>G | p.Leu219Val | missense_variant | 4/11 | 1 | NM_001320033.2 | ENSP00000396283.1 | ||
SLC22A14 | ENST00000273173.4 | c.655C>G | p.Leu219Val | missense_variant | 3/10 | 1 | ENSP00000273173.4 | |||
SLC22A14 | ENST00000466887.5 | c.259C>G | p.Leu87Val | missense_variant | 4/4 | 4 | ENSP00000442528.1 | |||
SLC22A14 | ENST00000496724.1 | n.1716C>G | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.655C>G (p.L219V) alteration is located in exon 3 (coding exon 3) of the SLC22A14 gene. This alteration results from a C to G substitution at nucleotide position 655, causing the leucine (L) at amino acid position 219 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at